Back to today’s briefing

Story perspectives

Health Canada Approves Updated COVID Vaccines for 2025-2026

8/26/2025

49 8

Summary

Story summary

Health Canada has approved updated COVID-19 vaccines from Pfizer and Moderna for the 2025-2026 season, targeting the LP.8.1 variant.
Moderna will manufacture doses in Laval, Quebec, and fill syringes in Cambridge, Ontario.
The vaccines are authorized for individuals aged six months and older, with specific guidance for high-risk groups.
Moderna plans to distribute the vaccines this fall, highlighting progress in Canadian biomanufacturing.

1 of 1

Story summary

Health Canada has approved updated COVID-19 vaccines from Pfizer and Moderna for the 2025-2026 season, targeting the LP.8.1 variant.
Moderna will manufacture doses in Laval, Quebec, and fill syringes in Cambridge, Ontario.
The vaccines are authorized for individuals aged six months and older, with specific guidance for high-risk groups.
Moderna plans to distribute the vaccines this fall, highlighting progress in Canadian biomanufacturing.